(via TheNewswire)
![](https://tnw-c.thenewswire.com/data/tnw/clients/logos/Av7F880Y.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/facebook.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/twitter.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/linkedIn.png)
Further to the Company’s news release dated
The RSUs vest on the following schedule:
- 662,500RSUs on
January 11, 2021 ;- 262,500RSUs on
July 11, 2021 ;- 262,500RSUs on
January 11, 2022 ;- 262,500RSUs on
July 11, 2022 ;- 100,000RSUs in increments of 50,000 upon completion of milestones related to the development of the Company’s commercial breast CT imaging system
The PSUs vest on the following schedule:
- 225,000PSUs upon FDA submission;
- 225,000upon first sale of the Company’s breast CT imaging system
ON BEHALF OF THE BOARD
Chief Executive Officer
Contact Information
For investor relations inquiries contact:
Phone: 1-778-962-0234
Email:IR@izocorp.com
For general inquiries contact:
Phone: 1-833-IZOCORP
Email:info@izocorp.com
About
The initial indication for use for breast CT as a diagnostic device has been confirmed. Forthcoming business objectives include identifying additional indications for use, development of accessories, and additional products, all aimed at making breast CT an indispensable tool for improving the outcomes of breast cancer.
Additional information about
Forward Looking Statements
This document may contain forward-looking statements that are based on the Company's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.
Copyright (c) 2021 TheNewswire - All rights reserved.
Copyright (c) 2021 TheNewswire - All rights reserved., source